Home > Insider Trading > Filing (0001562180-22-005637)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1395937	Syndax Pharmaceuticals Inc	SNDX	Pharmaceutical Preparations (2834)	320162505

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1507220	A Michael Metzger	C/O Syndax Pharmaceuticals, Inc. 35 Gatehouse Drive, Building D, Floor 3 Waltham MA 02451	Chief Executive Officer	No	No	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2022-07-06	15,009	$6.38	32,668	No	4	M	Direct
Common Stock	Disposition	2022-07-06	15,009	$21.07	17,659	No	4	S	Direct
Common Stock	Acquisiton	2022-07-07	100	$6.38	17,759	No	4	M	Direct
Common Stock	Disposition	2022-07-07	100	$21.00	17,659	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	S	Direct
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Options (Right to buy)	Disposition	2022-07-06	15,009	$0.00	15,009	$6.38
Common Stock	Stock Options (Right to buy)	Disposition	2022-07-07	100	$0.00	100	$6.38

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
0		2029-02-06	No	4	M	Direct
0		2029-02-06	No	4	M	Direct

Footnotes

The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 plan adopted by the Reporting Person. Following the sales reported in this Form 4, the Reporting Person has a total of 702,068 options to purchase shares of common stock that are vested and immediately exercisable and a total of 554,172 options to purchase shares of common stock that have not yet vested.
The sale prices ranged from $21.00 to $21.25.
This option vests periodically upon the Issuer achieving certain milestones.